Oct 8 (Reuters) - U.S. FDA:

* FDA SAYS IS REISSUING MAY 26, 2021 LETTER IN ITS ENTIRETY, TO REFLECT THAT DISTRIBUTION OF AUTHORIZED SOTROVIMAB WILL BE CONTROLLED BY U.S. GOVERNMENT Source text for Eikon: Further company coverage: